Treatment of Central Retinal Vein Occlusion Using Stem Cells Study

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 22, 2019

Primary Completion Date

November 7, 2023

Study Completion Date

November 9, 2023

Conditions
Central Retinal Vein Occlusion
Interventions
BIOLOGICAL

Autologous Bone Marrow CD34+ Stem Cells

Single intravitreal injection of autologous bone marrow CD34+ stem cells. The number of cells to be injected per eye will range from 800,000 to 10 million, depending on the yield of the bone marrow aspiration and the isolation procedure.

BIOLOGICAL

Sham Therapy

Sham bone marrow aspiration procedure that penetrates the skin, but does not penetrate the bone followed by sham intravitreal injection without penetration of the eye

Trial Locations (1)

95817

Department of Ophthalmology & Vision Science, University of California Davis Eye Center, Sacramento

All Listed Sponsors
collaborator

National Eye Institute (NEI)

NIH

collaborator

University of California, Davis

OTHER

lead

The Emmes Company, LLC

INDUSTRY

NCT03981549 - Treatment of Central Retinal Vein Occlusion Using Stem Cells Study | Biotech Hunter | Biotech Hunter